BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Resources | Government Scientific Source - ECPv6.15.16//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://resources.govsci.com
X-WR-CALDESC:Events for Resources | Government Scientific Source
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20160313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20161106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180720T080000
DTEND;TZID=America/New_York:20180720T170000
DTSTAMP:20260611T134319
CREATED:20180808T184803Z
LAST-MODIFIED:20180808T185751Z
UID:2177-1532073600-1532106000@resources.govsci.com
SUMMARY:Axion: SCREENING FOR ENVIRONMENTAL TOXINS WITH A HUMAN BRAIN IN A DISH MODEL
DESCRIPTION:In our daily lives we are exposed to thousands of commercially used chemicals. Many of these chemicals are not toxic at typical exposure levels\, but for thousands of chemicals\, toxicological information is lacking. The National Academy of Sciences report on ‘‘Toxicity testing in the 21st century’’ highlighted the need for efficient methods to screen chemicals (e.g. insecticides) for their potential to cause toxicity. \nWhen screening compounds for the potential to disrupt the nervous system\, measuring neural activity is crucial\, since many neurotoxins are known to disrupt ion channel\, and receptor activity in the absence of other biochemical or structural changes to the cell. In this Coffee Break Webinar\, Dr Lorena Saavedra (NeuCyte) discusses how measuring compound-induced changes to the spontaneous firing activity of human stem cell-derived neural cells in an MEA assay helped detect potentially harmful neurological side effects of compounds such as pyrethroid insecticides. \nWatch On Demand
URL:https://resources.govsci.com/event/screening-for-environmental-toxins-with-a-human-brain-in-a-dish-model/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/08/Axion-SCREENING-FOR-ENVIRONMENTAL-TOXINS-WITH-A-HUMAN-BRAIN-IN-A-DISH-MODEL.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180711T100000
DTEND;TZID=America/New_York:20180711T110000
DTSTAMP:20260611T134319
CREATED:20180621T162933Z
LAST-MODIFIED:20180709T132731Z
UID:912-1531303200-1531306800@resources.govsci.com
SUMMARY:Eppendorf: Culture of 3D Cell Aggregates in Perfusion
DESCRIPTION:Three-dimensional (3D) cell aggregates are of great interest for many applications\, including disease modeling\, drug toxicity assessment\, and manufacture of stem cell-based products. Stirred-tank bioreactors are promising culture systems for 3D cell aggregates\, as they allow efficient establishment and maintenance of cell aggregates\, process monitoring and control\, and process scale-up to larger volumes. Furthermore\, they can be operated in perfusion mode\, which allows 3D cell aggregates to be sustained longer than in traditional batch cultures.\n\nThis webcast will review a research example for process development with the human tumor cell line H157\, cultivated in stirred-tank mini bioreactors as 3D cell aggregates. \n\n\nRegister Here \n\n\n\nLearning Objectives: \n\nLearn about the challenges and benefits of perfusion cultivation for stem cells and 3D cell models\nGain insight on the impact of impeller geometry on cell growth and aggregate formation\nInteract with an expert in a live Q&A session\n\n\nNorth America | Europe Broadcasts:\nWednesday\, July 11\, 2018 at 10am EDT | 9am CDT | 3pm BST | 4pm CESTAsia Pacific Broadcast:\nWednesday\, July 11\, 2018 at 11:30am IST | 2pm CST | 3pm JST \n\n\n\n\n\nSpeaker:\nDr. Philipp Nold\, Infield Application Specialist\, Eppendorf Bioprocess Center\, Juelich\, Germany
URL:https://resources.govsci.com/event/culture-of-3d-cell-aggregates-in-perfusion/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/06/Culture-of-3D-Cell-Aggregates-in-Perfusion.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180629T110000
DTEND;TZID=America/New_York:20180629T120000
DTSTAMP:20260611T134319
CREATED:20180618T174824Z
LAST-MODIFIED:20180709T132622Z
UID:797-1530270000-1530273600@resources.govsci.com
SUMMARY:Agilent: Quantitation and Profiling Metabolomics and Translation to Clinical Analysis
DESCRIPTION:Measurement of these metabolites represents the digital readout of health.  A key aspect of metabolomics is the utilization of high resolution mass spectrometric approaches to detect and identify metabolites from biological fluids and tissues.  The use of multi-analyte analyses as well as high resolution mass spectrometric approaches has the potential to transform clinical diagnostics for the next generation. This presentation will discuss profiling and quantitative metabolomics techniques such as traditional LC-MS based approaches and new methods that utilize direction analysis approaches. \nLearning Objectives: \n\nDemonstrate the use of multianalyte metabolomic panels in clinical research\nDiscuss the application of high resolution mass spectrometry approaches to metabolomics\nUnderstand the utilization of bioinformatic tools for interpreting results.\n\nWatch Webinar on Demand \nFor Research Use Only. Not for use in diagnostic procedures \nCONTINUING EDUCATION CREDITS: P.A.C.E. CE | Florida CE \n \n  \nTimothy J Garrett\, PhD\nAssociate Professor\, University of Florida
URL:https://resources.govsci.com/event/quantitation-and-profiling-metabolomics-and-translation-to-clinical-analysis/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/06/Agilent-Webinar-June-29.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180620T150000
DTEND;TZID=America/New_York:20180620T160000
DTSTAMP:20260611T134319
CREATED:20180614T232032Z
LAST-MODIFIED:20180709T132528Z
UID:747-1529506800-1529510400@resources.govsci.com
SUMMARY:Qiagen: Rethinking TB Testing and Treatment in Pediatrics
DESCRIPTION:Join Dr. Sonia Qasba for a live interactive webinar event! \nOn June 1st\, the American Academy of Pediatrics released the new Red Book® 2018 edition\, which expands established AAP recommendations for TB blood testing in children. The AAP now preferentially recommends the use of TB blood tests (IGRAs) in BCG-vaccinated children aged 2 years and older.  \nJoin us for a live webinar event to learn more about the new AAP guidelines. During this program\, you’ll learn more about the rationale behind the new pediatric IGRA recommendations and LTBI treatment regimens\, while looking more broadly at how TB elimination efforts are increasingly focused on employing preventive methods in the primary care setting. \nView Webinar on Demand \n  \nPresenter:\nSonia Qasba\, MD\nSuburban Hospital\, part of Johns Hopkins Medicine
URL:https://resources.govsci.com/event/rethinking-tb-testing-and-treatment-in-pediatrics/
LOCATION:From your desktop or mobile device
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/06/Rethinking-TB-testing-and-treatment-in-Pediatrics.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180620T090000
DTEND;TZID=America/New_York:20180620T190000
DTSTAMP:20260611T134319
CREATED:20180619T193814Z
LAST-MODIFIED:20180709T132144Z
UID:838-1529485200-1529521200@resources.govsci.com
SUMMARY:Teledyne CETAC: An Introduction to the All New SimPrep Automated Liquid Handling Station
DESCRIPTION:The webinar will be presented three different times so be sure to select the appropriate time slot when registering on the registration page \n\n\n9:00 AM EDT / 8:00 AM CDT /  7:00 AM MDT / 6:00 AM PDT / 3:00 PM BST/ 5:00 PM IDT / 9:00 PM CST / 10:00 PM JST \n\n\n3:00 PM EDT / 2:00 PM CDT / 1:00 PM MDT / 12:00 Noon PDT / 8:00 PM BST / 10:00 PM IDT / 3:00 AM CST / 4:00 AM JST \n\n\n7:00 PM EDT / 6:00 PM CDT / 5:00 PM MDT / 4:00 PM PDT / 12:00 Midnight BST / 2:00 AM IDT / 7:00 AM CST / 8:00 AM JST \n\n\nCombining a Cetac Autosampler with a Hamilton Dual Syringe dilution system brings an all new fully automated prep station to the market. With Hamilton accuracy and Cetac reliability the SimPrep gives the best performance in the market for sample preparation. \n This system does more than simply dilute samples. In addition to dilutions the SimPrep can dispense\, mix\, spike samples\, do serial dilutions\, split samples for multiple preps\, and even prepare your calibration standards. \n\nRequest On Demand Webinar \n  \nJacob Herrington\, Teledyne CETAC Product Manager will be presenting this webinar.  \nThe presentation will last approximately 30 minutes and will include a question and answer session to follow
URL:https://resources.govsci.com/event/an-introduction-to-the-all-new-simprep-automated-liquid-handling-station/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/06/Teledyne.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180620T080000
DTEND;TZID=America/New_York:20180620T170000
DTSTAMP:20260611T134319
CREATED:20180808T185624Z
LAST-MODIFIED:20180808T185709Z
UID:2180-1529481600-1529514000@resources.govsci.com
SUMMARY:Axion: PRECISION MEDICINE - EXTINGUISHING THE FIRE OF THE BURNING MAN
DESCRIPTION:“Man on Fire” syndrome\, also known as Inherited Erythromelalgia (IEM)\, is a chronic pain syndrome characterized by burning pain in the hands and feet. The chronic pain of most patients with IEM cannot be relieved by common pain killers making this disease a major unmet medical need. \nPrecision Medicine is an approach that tailors the prescribed medical treatment to the individual’s genetic makeup. In this Coffee Break Webinar\, Dr Yang Yang (Purdue University) discusses advances in the treatment of IEM using a pharmacogenomic approach. The drug responsiveness of different genetic mutations associated with IEM were probed in an in vitro Maestro MEA assay\, with the results helping to predict the effective treatment of these IEM patients in the clinic. \nThis precision medicine approach\, guided by genomic analysis and functional profiling\, provides a promising new way to extinguish the fire of the burning man. \nWatch On Demand
URL:https://resources.govsci.com/event/precision-medicine-extinguishing-the-fire-of-the-burning-man/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180619T120000
DTEND;TZID=UTC:20180619T130000
DTSTAMP:20260611T134319
CREATED:20180613T182457Z
LAST-MODIFIED:20180712T125505Z
UID:632-1529409600-1529413200@resources.govsci.com
SUMMARY:Leica Biosystems: Identifying Respiratory Disease in Pathology
DESCRIPTION:Identifying respiratory pathology will look at the entire spectrum of making a pathology diagnosis. We will start by explaining various specimen collection methods. Once the specimen is collected and processed in histology or cytology\, this presentation will look at different staining techniques and IHC/molecular methods used to make a diagnosis. The presentation will conclude with a few case studies that will incorporate the presentation to diagnosis of a respiratory condition. \nWe will cover the following webinar learning objectives: \n\nLearn the types of cells found in respiratory pathology.\nUnderstand proper specimen collection methods.\nIdentify IHC stains and molecular techniques used in common diagnoses.\n\n  \nWatch Webinar on Demand \n  \nAllison Eck is the lead histotechnologist at Doylestown Hospital in Pennsylvania. She has been a histotechnologist for 15 years after graduating with a degree in histotechnology from Harford Community College in Maryland and a bachelor’s degree in biology from Lycoming College in Pennsylvania. She holds her histotechnologist (HTL) and qualification in laboratory safety (QLS) certifications through the ASCP\, as well as her Allied Health Instructor (AHI) certification through AMT. Allison has spoken at a variety of professional conferences on respiratory disease as well as lab safety and ergonomics. \n  \n 
URL:https://resources.govsci.com/event/identifying-respiratory-disease-in-pathology/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/06/Pathology-Leaders.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180614T100000
DTEND;TZID=UTC:20180614T110000
DTSTAMP:20260611T134319
CREATED:20180612T192729Z
LAST-MODIFIED:20180709T130951Z
UID:615-1528970400-1528974000@resources.govsci.com
SUMMARY:Panel discussion on large molecule quantification by LC–MS
DESCRIPTION:The increasing importance of large molecule therapeutics has been coupled with advancements in LC–MS technology\, opening up new opportunities. Typically\, large molecules are analyzed using ligand-binding assays but with advanced progress in MS technology the community has seen increased success in overall sensitivity and selectivity. However\, what does this mean for future analysis and what challenges remain for the use of LC–MS for large molecules. \nIn this free panel discussion\, our experts will provide insights into their own research with large molecules including the challenges they have had to overcome\, key trends they have seen and their future outlook of the development of this field. There is also an opportunity for your own questions to be answered in the live Q&A. \nWhat will you learn? \n\nBest practices of protein quantification and digestion\nConsiderations for Top-down vs Bottom-up approaches\nFuture developments (including enhancing assay sensitivity)\n\nWatch Webinar on Demand \nSpeakers\n\n\n\n\nMichael Blackburn\nBioanalytical Scientist\, Method Development\nARCINOVA (Alnwick\, UK)\n\n\nMichael completed postgraduate work at the University of Wales (Bangor\, UK) and began work for the government in the UK\, measuring the concentrations of pollutants in aquatic samples by gas and later liquid chromatography-mass spectrometry. He later joined the pharmaceutical industry with Sanofi (Guildford\, UK)\, as a mass spectrometrist\, doing bioanalytical and drug metabolism studies. Since then he has worked as a Principle Investigator and Head of Method Development at Covance (Alnwick\, UK) and latterly for ARCINOVA as a method developer. The development of better insulin assays using hybrid MS approaches has been a major interest for about 10 years. \n\n\n\n\n\nKees Bronsema\nSenior Scientist\nPRA (NC\, USA)\n\n\nKees Bronsema\, Senior Scientist in Bioanalytical Method Development LC–MS/MS at PRA (Groningen\, Netherlands)\, has nearly 20 years of experience in the field. Initially\, the focus was on small molecule quantitation but following the trend towards biopharmaceuticals\, he completed postgraduate work on absolute quantitation of proteins and peptides with LC–MS/MS at the University of Groningen (Groningen\, Netherlands) in 2015. His current role is to develop analytical methods for proteins and peptides with LC–MS/MS\, which include both endogenous biomarkers and biopharmaceuticals. \n\n\n\n\n\nCory E. Muraco\nSenior R&D Scientist\nMilliporeSigma (MA\, USA)\n\n\nCory is a Senior R&D Scientist in the Liquid Separations R&D group at MilliporeSigma\, Bellefonte\, PA. He completed his graduate studies at Youngstown State University in 2013\, focusing on the analysis and characterization of oxidized proteins. Upon graduation\, Cory joined MilliporeSigma in 2013\, first joining the chemical standards R&D group\, then transferring to the liquid separations R&D group. His current role at MilliporeSigma is to research\, develop\, and present on new particle technology for improved chromatographic separations of both small and large molecules as well as to develop new methodologies for characterizing biomacromolecules by several modes of chromatography. \n*The life science business of Merck KGaA\, Darmstadt\, Germany operates as MilliporeSigma in the U.S. and Canada. \n\n\n\n\n\nOmnia A. Ismaiel\nSenior Research Scientist\nPPD (NC\, USA)\n\n\nDr Omnia Ismaiel is a Senior Research Scientist at Bioanalytical Labs\, Pharmaceutical Product Development\, USA. She is also an Associate Professor of Pharmaceutical Analytical Chemistry at Faculty of Pharmacy (Zagazig University\, Egypt) and Affiliate Assistant Professor at School of Pharmacy (Virginia Commonwealth University\, VA\, USA). She was a Postdoctoral Fellow at Virginia Commonwealth University and a Postdoctoral Research Associate at University of Georgia\, USA. She has been in the Bioanalysis field for more than 12 years. and has many years of teaching experience too. She is currently working on development and validation of Bioanalytical LC–MS methods for therapeutic peptides/proteins\, glycan analysis and high-resolution MS. \n\n\n\n\n\nRobert Wheller\nPrincipal Scientist\nLGC (Cambridge\, UK)\n\n\nRobert is a principal scientist at LGC where he leads of a group of scientists focused on providing a large molecule LC-MS bioanalytical service. He has expertise in the bioanalysis of small molecules\, oligonucleotides\, peptides and proteins utilizing LC-MS/MS and ligand binding assay technologies. He has developed a keen interest in the implementation of immunoaffinity\, 2D-LC and HR-MS techniques for protein LC-MS quantification workflows. \n\n\n\n\n\nHongbin Yu\nDirector\nBoehringer Ingelheim Pharmaceuticals\n\n\nHongbin Yu is the Director of Bioanalytical Mass Spectrometry in the DMPK department at Boehringer Ingelheim Pharmaceuticals in Ridgefield (CT\, USA). He obtained his Ph.D in organic chemistry from the University of Missouri-Columbia (MO\, USA). He joined Boehringer Ingelheim in 2006 and has supported drug development for both small and large molecules. For small molecules\, his responsibilities focused on biotransformation and bioanalysis utilizing LC–MS. For large molecules\, his responsibilities included supervising immunoassay development/validation\, critical reagent generation and pharmacokinetic analysis. He currently oversees regulated and non-regulated bioanalysis for small molecules by LC–MS and large molecules by hybrid LBA/LC–MS.
URL:https://resources.govsci.com/event/panel-discussion-on-large-molecule-quantification-by-lc-ms/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/06/Webinar-Large-Molecule-Quantification-by-LC-MS.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180523T083000
DTEND;TZID=UTC:20180523T153000
DTSTAMP:20260611T134319
CREATED:20180529T193410Z
LAST-MODIFIED:20180709T130441Z
UID:492-1527064200-1527089400@resources.govsci.com
SUMMARY:Horiba: A Seminar on the Newest Breakthroughs in Nanoparticle Measurements
DESCRIPTION:HORIBA Instruments and Microfluidics present a seminar on the newest breakthroughs in nanoparticle measurements \n\n\nWednesday\, May 23rd\, 2018\n\nHoliday Inn Gaithersburg\n2 Montgomery Village Ave\nGaithersburg MD 20879\n301-948-8900 \n\nMarinella Sandros\, Ph. D.\, Horiba Scientific will present “Designed Nano-Bio interfaces using Surface Plasmon Resonance imaging for Biomedical Application.” \nNew Technology for the Formulation and Characterization of Mono & Polydisperse Nanomaterials for the Pharma\, Biotech Extracellular Vesicle\, and Virology Markets\nRequest recording from carol.madden@horiba.com | P: 800-446-7422 x 1133 | F: 949-468-1790  \nFeaturing guest speakers and acknowledged experts: \n• Jeffrey D. Clogston\, Ph.D – Leidos Biomedical Research\n• Jan “Kuba” Tatarkiewicz\, Ph.D – MANTA Instruments\n• Pushpendra Singh\, Ph.D – WRAIR\n• Niaz Khan – University of Maryland\n• Philo Morse – Particle Sciences\n• Gary R. Matyas\, Ph.D – WRAIR\n• Andrew Lees\, Ph.D – Fina Biosolutions LLC \nEmphasis of the seminar will be on applications\, problem solving and new developments in nanoparticle sciences. The ViewSizer® 3000 and LA-960 instruments\, and MicroFluidizer technology will be featured.
URL:https://resources.govsci.com/event/a-seminar-on-the-newest-breakthroughs-in-nanoparticle-measurements/
LOCATION:Holiday Inn Gaithersburg\, 2 Montgomery Village Ave\, Gaithersburg\, MD\, 20879\, United States
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170919T080000
DTEND;TZID=America/New_York:20170919T170000
DTSTAMP:20260611T134319
CREATED:20180702T224830Z
LAST-MODIFIED:20180709T130344Z
UID:1157-1505808000-1505840400@resources.govsci.com
SUMMARY:Essen BioScience: Quantitative Live-Cell Analysis of Human iPSC-derived Neurons
DESCRIPTION:Optimization of culture conditions and evaluation of cell health \nWatch Recording On Demand \nA major limitation in studying human diseases affecting the nervous system is the ability to culture\, monitor and analyze neuronal cells that accurately represent human phenotypes of these disorders. The use of human induced pluripotent stem cell (hiPSC)-derived neurons has provided a new approach aimed at modeling neurological diseases. Monitoring neuronal morphology and cell health in long-term culture is critical for the characterization and evaluation of these novel model systems. Traditional approaches rely on endpoint assays and imaging techniques that require immunochemical staining\, which provide limited real-time kinetic information. In this webinar\, we highlight optimal culture conditions and demonstrate the ability of the IncuCyte S3® approach for real-time\, long-term quantitative analysis of iPSC-derived neuronal cell health. \nWatch this webinar to learn how:  \n\nYou can easily optimize culture conditions for (hiPSC)-derived neurons\nReal-time live-cell analysis using phase (monoculture) or fluorescent (co-culture) NeuroTrack software can be used to visualize and quantify neurite dynamics\nOther live-cell phenotypic assays (e.g. apoptosis) are used to monitor neuronal cell health and validate mechanisms of action\n\nSpeaker: Aaron Overland | Senior Application Scientist\, Essen BioScience \nAaron joined Essen BioScience as a Senior Application Scientist in September of 2016 and is leading projects focused on developing new reagents and applications for live cell analysis of neuronal health and function using the IncuCyte system. Aaron earned his BS and PhD in Neuroscience from the University of Minnesota\, where he investigated cellular signaling mechanisms mediating analgesic synergy between agonists acting at delta-opioid and alpha2-adrenergic receptors in the spinal cord. His postdoctoral work at University of California\, San Diego expanded upon his foundation in cell-based assays of G protein-coupled receptor signaling\, focusing on the discovery of a novel signaling module for G protein-mediated transactivation of EFGR in cardiomyocytes and fibroblasts.
URL:https://resources.govsci.com/event/quantitative-live-cell-analysis-of-human-ipsc-derived-neurons/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/07/Quantitative-Live-Cell-Analysis-of-Human-iPSC-Derived-Neurons.png
END:VEVENT
END:VCALENDAR